These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17446098)

  • 21. Proceedings: Cancer chemotherapy: a broad overview.
    Perry S
    Proc Natl Cancer Conf; 1972; 7():103-8. PubMed ID: 4128786
    [No Abstract]   [Full Text] [Related]  

  • 22. Actions of human telomerase beyond telomeres.
    Cong Y; Shay JW
    Cell Res; 2008 Jul; 18(7):725-32. PubMed ID: 18574498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomeres and aging.
    Aubert G; Lansdorp PM
    Physiol Rev; 2008 Apr; 88(2):557-79. PubMed ID: 18391173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Need for new approach to chemotherapy of cancer.
    Korgaonkar KS
    Panminerva Med; 1976; 18(3-4):121-4. PubMed ID: 1256901
    [No Abstract]   [Full Text] [Related]  

  • 25. Calcium and cancer: targeting Ca2+ transport.
    Monteith GR; McAndrew D; Faddy HM; Roberts-Thomson SJ
    Nat Rev Cancer; 2007 Jul; 7(7):519-30. PubMed ID: 17585332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting telomerase for cancer therapeutics.
    Shay JW; Keith WN
    Br J Cancer; 2008 Feb; 98(4):677-83. PubMed ID: 18231105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide.
    Wang X; Wang G; Dong D; Fu S; Yang B
    Exp Toxicol Pathol; 2008 Sep; 60(6):481-8. PubMed ID: 18606528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel therapeutic applications of cardiac glycosides.
    Prassas I; Diamandis EP
    Nat Rev Drug Discov; 2008 Nov; 7(11):926-35. PubMed ID: 18948999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of vascular access ports in femoral veins of dogs and cats with cancer.
    Cahalane AK; Rassnick KM; Flanders JA
    J Am Vet Med Assoc; 2007 Nov; 231(9):1354-60. PubMed ID: 17975994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomerase activation in neoplastic cell immortalization and tumour progression.
    Looi LM; Ng MH; Cheah PL
    Malays J Pathol; 2007 Jun; 29(1):33-5. PubMed ID: 19105326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trial of anticancer drug in dogs.
    Carvalho S; Stell A; Lara-Garcia A
    Vet Rec; 2013 Jul; 173(1):23-4. PubMed ID: 23832909
    [No Abstract]   [Full Text] [Related]  

  • 32. Activin inhibits telomerase activity in cancer.
    Katik I; Mackenzie-Kludas C; Nicholls C; Jiang FX; Zhou S; Li H; Liu JP
    Biochem Biophys Res Commun; 2009 Nov; 389(4):668-72. PubMed ID: 19769941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Apoptosis and activity changes of telomerase induced by essential oil from pine needles in HepG2 cell line].
    Wei FX; Li MY; Song YH; Li HZ
    Zhong Yao Cai; 2008 Aug; 31(8):1197-200. PubMed ID: 19112901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telomere length in normal and neoplastic canine tissues.
    Cadile CD; Kitchell BE; Newman RG; Biller BJ; Hetler ER
    Am J Vet Res; 2007 Dec; 68(12):1386-91. PubMed ID: 18052745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomeres and telomerase in leukaemia and lymphoma.
    Davison GM
    Transfus Apher Sci; 2007 Aug; 37(1):43-7. PubMed ID: 17766184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
    Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C
    Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caps and cancer.
    Mitchell A
    Nat Rev Mol Cell Biol; 2000 Oct; 1(1):8. PubMed ID: 11413483
    [No Abstract]   [Full Text] [Related]  

  • 38. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines.
    Parsch D; Brassat U; Brümmendorf TH; Fellenberg J
    Cancer Invest; 2008 Jul; 26(6):590-6. PubMed ID: 18584350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomere dysfunction and telomerase activation in cancer--a pathological paradox?
    Calcagnile O; Gisselsson D
    Cytogenet Genome Res; 2007; 118(2-4):270-6. PubMed ID: 18000380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway.
    Kelland L
    Clin Cancer Res; 2007 Sep; 13(17):4960-3. PubMed ID: 17785545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.